CA
NZ
UK
AU
IND
US
…
Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite and vespel/graphite sealing components for use by original equipment manufacturers in the field of gas/liquid chromatography in the chemical analysis industries. In addition, the company offers solvent chillers and refrigerated transportation products; and UV detectors and vial products. It serves hospitals, diagnostic laboratories, pharmaceutical and biotech companies, universities, governments, and private sector research facilities, as well as cold chain management, chemical, and industrial companies. The company was founded in 1999 and is based in Orem, Utah.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 0.21M | 0.17M | -0.46M | 0.09M | 0.94M |
| Net income | 0.21M | 0.17M | -0.46M | 0.09M | 0.94M |
| Selling general administrative | - | - | 0.39M | 1.06M | 1.04M |
| Selling and marketing expenses | - | - | 0.65M | - | - |
| Gross profit | 0.56M | 0.56M | 0.60M | 1.22M | 1.93M |
| Reconciled depreciation | - | - | 0.06M | 0.06M | 0.06M |
| Ebit | 0.17M | 0.17M | -0.47M | - | 0.83M |
| Ebitda | 0.25M | 0.24M | -0.41M | 0.15M | 1.00M |
| Depreciation and amortization | 0.08M | 0.07M | 0.06M | - | - |
| Operating income | 0.17M | 0.13M | -0.47M | 0.09M | 0.83M |
| Other operating expenses | 1.45M | 1.75M | 1.55M | - | - |
| Interest expense | - | - | - | - | 0.00M |
| Tax provision | - | - | 0.00M | 0.00M | 0.00M |
| Net interest income | - | - | - | - | 0.00M |
| Income tax expense | - | 0.00M | 0.00M | 0.00M | - |
| Total revenue | 1.61M | 1.88M | 1.08M | 2.04M | 2.81M |
| Total operating expenses | 0.39M | 0.43M | 1.06M | 1.95M | 1.99M |
| Cost of revenue | 1.05M | 1.32M | 0.48M | 0.82M | 0.88M |
| Total other income expense net | 0.04M | 0.04M | 0.01M | - | 0.11M |
| Net income from continuing ops | - | - | -0.46M | 0.09M | 0.94M |
| Net income applicable to common shares | - | - | - | - | 0.94M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 2.81M | 2.31M | 2.67M | 2.45M | 2.48M |
| Other current assets | 0.01M | 0.03M | 0.01M | 0.02M | - |
| Total liab | 0.53M | 0.25M | 0.78M | 0.15M | 0.30M |
| Total stockholder equity | 2.27M | 2.06M | 1.89M | 2.30M | 2.18M |
| Other current liab | 0.37M | - | 0.03M | - | 0.12M |
| Common stock | 0.86M | 0.86M | 0.86M | - | 0.85M |
| Capital stock | - | - | 0.86M | 0.85M | 0.85M |
| Retained earnings | -18.89M | -19.10M | -19.27M | -18.81M | -18.90M |
| Good will | 0.06M | 0.06M | 0.06M | 0.06M | 0.06M |
| Other assets | - | 0.00M | - | - | 0.00M |
| Cash | 1.88M | 1.01M | 1.28M | 1.38M | 1.47M |
| Total current liabilities | 0.53M | 0.15M | 0.60M | 0.15M | 0.24M |
| Current deferred revenue | - | - | 0.45M | - | - |
| Net debt | -1.77M | -0.82M | -1.04M | - | - |
| Short term debt | 0.11M | 0.10M | 0.06M | - | - |
| Short long term debt total | 0.11M | 0.20M | 0.24M | - | - |
| Other stockholder equity | 20.30M | 20.30M | 20.30M | - | - |
| Property plant equipment | - | - | - | - | 0.11M |
| Total current assets | 2.66M | 2.09M | 2.37M | 2.33M | 2.31M |
| Net tangible assets | - | - | - | - | 2.12M |
| Net receivables | 0.08M | 0.32M | 0.11M | 0.13M | 0.18M |
| Inventory | 0.70M | 0.72M | 0.97M | 0.80M | 0.62M |
| Accounts payable | 0.06M | 0.05M | 0.06M | 0.08M | 0.07M |
| Non currrent assets other | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Non current assets total | 0.15M | 0.23M | 0.30M | 0.12M | 0.17M |
| Capital lease obligations | - | - | 0.24M | 0.06M | 0.11M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to liabilities | - | -0.09M | 0.00M | -0.27M | 0.06M |
| Net borrowings | - | - | - | 0.10M | -0.00M |
| Total cash from financing activities | - | - | 0.00M | 0.11M | -0.00M |
| Change to operating activities | - | -0.05M | -0.06M | -0.06M | -0.02M |
| Net income | -0.46M | 0.09M | 0.94M | 0.66M | -0.20M |
| Change in cash | -0.10M | -0.09M | 0.83M | 0.09M | 0.33M |
| Begin period cash flow | 1.38M | 1.47M | 0.64M | 0.56M | 0.22M |
| End period cash flow | 1.28M | 1.38M | 1.47M | 0.64M | 0.56M |
| Total cash from operating activities | -0.10M | -0.09M | 0.83M | -0.03M | 0.34M |
| Depreciation | 0.06M | 0.06M | 0.06M | 0.06M | 0.00M |
| Change to inventory | -0.17M | -0.17M | -0.19M | -0.19M | -0.11M |
| Change to account receivables | 0.02M | 0.05M | 0.16M | -0.22M | 0.04M |
| Other cashflows from financing activities | -0.00M | - | - | 0.01M | 0.01M |
| Change to netincome | - | 0.03M | -0.08M | -0.01M | 0.20M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change receivables | - | - | - | - | 0.04M |
| Cash flows other operating | - | - | - | - | -0.02M |
| Cash and cash equivalents changes | - | - | - | - | 0.33M |
| Change in working capital | -0.20M | -0.27M | -0.08M | -0.74M | 0.30M |
| Stock based compensation | 0.06M | 0.03M | - | - | 0.20M |
| Other non cash items | 0.44M | - | 0.03M | -0.01M | 0.03M |
| Free cash flow | -0.10M | -0.09M | 0.83M | -0.03M | 0.34M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| RSCF Reflect Scientific Inc |
- -% |
0.06 | - | - | 2.59 | 1.63 | 1.15 | 222.75 |
| ISRG Intuitive Surgical Inc |
-8.88 1.97% |
440.65 | 43.30 | 31.35 | 12.25 | 7.35 | 11.63 | 30.22 |
| ESLOF EssilorLuxottica Société anonyme |
-2.56 1.26% |
200.18 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
-1.98 1.94% |
99.87 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
0.83 0.39% |
215.35 | 31.62 | 13.76 | 2.25 | 2.04 | 2.93 | 13.40 |
Reflect Scientific, Inc., through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide. The company offers Cryometrix ultra-low temperature and blast freezers, which are used to store various products, including blood and cancer vaccines. It also provides laboratory consumables and disposables, such as filtration and purification products, customized sample handling vials, electronic wiring assemblies, high temperature silicone, and graphite and vespel/graphite sealing components for use by original equipment manufacturers in the field of gas/liquid chromatography in the chemical analysis industries. In addition, the company offers solvent chillers and refrigerated transportation products; and UV detectors and vial products. It serves hospitals, diagnostic laboratories, pharmaceutical and biotech companies, universities, governments, and private sector research facilities, as well as cold chain management, chemical, and industrial companies. The company was founded in 1999 and is based in Orem, Utah.
| Name | Title | Year Born |
|---|---|---|
| Mr. Kim Boyce | Founder, Chairman, CEO, CFO & Pres | 1955 |
| Mr. William Grant Moon | VP of Engineering & Director | 1950 |
| Mr. Thomas A. Tait | VP, Sec. & Director | 1957 |
| Mr. Eric Pierson | Managing Director of Miralogix | 1962 |
| Dr. Craig W. Morrison M.D. | Chairman of Technical Advisory Board & Technical Advisor | 1944 |
| Mr. Kim Boyce | Founder, Chairman, CEO, CFO & President | 1955 |
| Mr. Thomas A. Tait | VP, Secretary & Director | 1957 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.40%
Communication Services
-0.45%
Consumer Cyclical
-0.55%
Consumer Defensive
-0.01%
Energy
-0.01%
Financial Services
-0.40%
Financials
-0.15%
Healthcare
-1.15%
Industrials
-0.46%
Real Estate
-0.29%
Technology
-1.22%
Utilities
-0.10%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
+0.55%
Please wait processing your request...